Viatris (VTRS) Interest Coverage Ratio Growth (3y) (2022 - 2026)
Viatris (VTRS) Interest Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | -75.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -87.25% |
| Mar 31, 2026 | -32.31% |
| Dec 31, 2025 | -16.43% |
| Sep 30, 2025 | 76.19% |
| Jun 30, 2025 | -10.31% |
| Mar 31, 2025 | -108.58% |
| Dec 31, 2024 | -41.89% |
| Sep 30, 2024 | 113.31% |
| Jun 30, 2024 | -326.70% |
| Mar 31, 2024 | 43.77% |
| Dec 31, 2023 | 19.14% |
| Sep 30, 2023 | 0.49% |
| Jun 30, 2023 | 36.44% |
| Mar 31, 2023 | -48.61% |
| Dec 31, 2022 | -40.71% |